274 related articles for article (PubMed ID: 31545648)
1. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
Frid MG; McKeon BA; Thurman JM; Maron BA; Li M; Zhang H; Kumar S; Sullivan T; Laskowsky J; Fini MA; Hu S; Tuder RM; Gandjeva A; Wilkins MR; Rhodes CJ; Ghataorhe P; Leopold JA; Wang RS; Holers VM; Stenmark KR
Am J Respir Crit Care Med; 2020 Jan; 201(2):224-239. PubMed ID: 31545648
[No Abstract] [Full Text] [Related]
2. Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
Frid MG; Thurman JM; Hansen KC; Maron BA; Stenmark KR
Glob Cardiol Sci Pract; 2020 Apr; 2020(1):e202001. PubMed ID: 32478115
[TBL] [Abstract][Full Text] [Related]
3. A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
Dai L; Chen Y; Wu J; He Z; Zhang Y; Zhang W; Xie Y; Zeng H; Zhong X
J Transl Med; 2024 Feb; 22(1):164. PubMed ID: 38365806
[TBL] [Abstract][Full Text] [Related]
4. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
5. Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
El Kasmi KC; Pugliese SC; Riddle SR; Poth JM; Anderson AL; Frid MG; Li M; Pullamsetti SS; Savai R; Nagel MA; Fini MA; Graham BB; Tuder RM; Friedman JE; Eltzschig HK; Sokol RJ; Stenmark KR
J Immunol; 2014 Jul; 193(2):597-609. PubMed ID: 24928992
[TBL] [Abstract][Full Text] [Related]
6. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.
Li M; Riddle SR; Frid MG; El Kasmi KC; McKinsey TA; Sokol RJ; Strassheim D; Meyrick B; Yeager ME; Flockton AR; McKeon BA; Lemon DD; Horn TR; Anwar A; Barajas C; Stenmark KR
J Immunol; 2011 Sep; 187(5):2711-22. PubMed ID: 21813768
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.
Nakahara M; Ito H; Skinner JT; Lin Q; Tamosiuniene R; Nicolls MR; Keegan AD; Johns RA; Yamaji-Kegan K
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L416-L428. PubMed ID: 34189964
[TBL] [Abstract][Full Text] [Related]
8. Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
Yu YA; Malakhau Y; Yu CA; Phelan SJ; Cumming RI; Kan MJ; Mao L; Rajagopal S; Piantadosi CA; Gunn MD
J Immunol; 2020 Mar; 204(6):1474-1485. PubMed ID: 31996456
[TBL] [Abstract][Full Text] [Related]
9. Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice.
Bauer EM; Zheng H; Comhair S; Erzurum S; Billiar TR; Bauer PM
PLoS One; 2011; 6(12):e28578. PubMed ID: 22194859
[TBL] [Abstract][Full Text] [Related]
10. The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
Kumar R; Mickael C; Chabon J; Gebreab L; Rutebemberwa A; Garcia AR; Koyanagi DE; Sanders L; Gandjeva A; Kearns MT; Barthel L; Janssen WJ; Mauad T; Bandeira A; Schmidt E; Tuder RM; Graham BB
Am J Respir Crit Care Med; 2015 Oct; 192(8):998-1008. PubMed ID: 26192556
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation contributes to hypoxia-induced inflammation.
Delaney C; Davizon-Castillo P; Allawzi A; Posey J; Gandjeva A; Neeves K; Tuder RM; Di Paola J; Stenmark KR; Nozik ES
Am J Physiol Lung Cell Mol Physiol; 2021 Mar; 320(3):L413-L421. PubMed ID: 33264579
[TBL] [Abstract][Full Text] [Related]
12. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
Kumar S; Frid MG; Zhang H; Li M; Riddle S; Brown RD; Yadav SC; Roy MK; Dzieciatkowska ME; D'Alessandro A; Hansen KC; Stenmark KR
JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34499621
[TBL] [Abstract][Full Text] [Related]
13. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
Ruseva MM; Takahashi M; Fujita T; Pickering MC
Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761
[TBL] [Abstract][Full Text] [Related]
14. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.
Ciuclan L; Hussey MJ; Burton V; Good R; Duggan N; Beach S; Jones P; Fox R; Clay I; Bonneau O; Konstantinova I; Pearce A; Rowlands DJ; Jarai G; Westwick J; MacLean MR; Thomas M
Am J Respir Crit Care Med; 2013 Jan; 187(1):78-89. PubMed ID: 23087024
[TBL] [Abstract][Full Text] [Related]
15. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.
Rafikova O; Williams ER; McBride ML; Zemskova M; Srivastava A; Nair V; Desai AA; Langlais PR; Zemskov E; Simon M; Mandarino LJ; Rafikov R
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):334-345. PubMed ID: 29652520
[TBL] [Abstract][Full Text] [Related]
17. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
18. An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.
Redinus K; Baek JH; Yalamanoglu A; Shin HKH; Moldova R; Harral JW; Swindle D; Pak D; Ferguson SK; Nuss R; Hassell K; Nozik-Grayck E; Palmer AF; Fini MA; Karoor V; Stenmark KR; Buehler PW; Irwin DC
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391342
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
[TBL] [Abstract][Full Text] [Related]
20. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
